Rheumatoid Arthritis in the Aged: Incidence and Optimal Management

Drugs & Aging

Volumn 3, Issue 6, 1993, Pages 487-501

  Nesher, Gideon ^a,b   Moore, Terry L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; HUMAN; REVIEW; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; HUMAN;

EID: 0027687504     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/00002512-199303060-00003     Document Type: Review

References (180)

1. The mechanisms of action of nonsteroidal antiinflammatory drugs
2. Rheumatoid arthritis in old age
3. Pharmacokinetics of ketoprofen in the elderly
4. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized controlled study
5. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients: influence of menopausal state
6. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites
7. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
8. Immunosuppressive drugs and corticosteroids in the treatment of RA
9. Surgical treatment of arthritis in the elderly
10. Acute renal effects of sulindac and indomethacin in chronic renal failure
11. Prevalence of Rheumatoid arthritis, osteoarthritis, chondrocalcinosis and gouty arthritis at age 79
12. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine
13. Salsalate in the treatment of RA: a double blind clinical and gastroscopic trial versus piroxicam
14. Renal complications of nonsteroidal antiinflammatory drugs; identification and monitoring of those at risk
15. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac
16. Sulindac does not spare the kidney
17. Anarthritic rheumatoid arthritis: The polymyalgia dilemma
18. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients
19. Methotrexate-induced liver abnormalities in rheumatoid arthritis
20. Nonsteroidal antiinflammatory drugs — differences and similarities
21. The onset of rheumatoid arthritis in the aged
22. Administration of folinic acid after methotrexate in patients with rheumatoid arthritis
23. Sulindac: a potentially renal sparing nonsteroidal anti-inflammatory drug
24. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis
25. Arthritis in the elderly
26. The Felty Syndrome: A case-matched study of clinical manifestations and outcome, serologic features and immunogenetic associations
27. Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review
28. Gastroscopic evaluation of anti-inflammatory agents
29. Rheumatoid arthritis in the elderly
30. Nonsteroidal anti-inflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro
31. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis
32. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin
33. Cytotoxic drugs: Their clinical application to the rheumatic diseases
34. Renal syndromes associated with nonsteroidal antiinflammatory drugs
35. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation
36. Benign rheumatoid arthritis of the aged
37. Cimetidine for peptic ulcer in patients with arthritis
38. Correlation of serological indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis
39. Treatment of rheumatoid arthritis patients with an anti-CD5 immuno-conjugate
40. Abolition by omeprazole of aspirin-induced gastric mucosal injury in man
41. Interactions between nonsteroidal anti-inflammatory drugs and antihypertensives and diuretics
42. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration
43. Review of auranofin, an oral chrysotherapeutic agent
44. Care and training of elderly patients with rheumatoid arthritis
45. Rheumatoid arthritis in the elderly
46. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases
47. Ocular effects and safety of antimalarial agents
48. Rheumatoid Arthritis in the aged
49. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine
50. Aspirin and bleeding peptic ulcers in the elderly
51. Interactions of diuretics and nonsteroidal anti-inflammatory drugs in man
52. Comparing second line drugs for RA: Efficacy/toxicity tradeoffs
53. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factors
54. Clinically important interactions of nonsteroidal anti-inflammatory drugs with other medications
55. Methotrexate in rheumatoid arthritis
56. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate
57. Clinical comparison of ibuprofen, fenoprofen calcium naproxen and tolmentin sodium in rheumatoid arthritis
58. Realistic guidelines of corticosteroid therapy in rheumatic disease
59. Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis
60. Brief report: Cognitive dysfunction associated with naproxen and ibuprofen in the elderly
61. Gold compounds
62. Prevention of NSAID-induced gastric ulcer with misoprostol: multicenter, double-blind, placebo-controlled trial
63. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders
64. Absorption and disposition of ibuprofen in the elderly
65. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
66. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
67. Osteoporosis: Diagnosis and management
68. Rheumatoid pericarditis: Clinical features and survival
69. Management of rheumatoid arthritis
70. Low dose prednisone therapy in rheumatoid arthritis: A double blind study
71. Renal physiology of the prostaglandins and the effects of nonsteroidal anti-inflammatory agents on the kidney
72. The relation of polymyalgia rheumatica to rheumatoid arthritis
73. Exercise in patients with inflammatory arthritis and connective tissue disease
74. The mode of action of anti-inflammatory drugs which prevent peroxidation of arachidonic acid
75. Central nervous system side effects of nonsteroidal anti-inflammatory drugs
76. Treatment of rheumatoid arthritis with an anti-CD 4 monoclonal antibody
77. Penicillamine
78. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy
79. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal anti-inflammatory agents in patients treated with a combination of cimetidine, antacids, and enteric-coated aspirin
80. Nonsteroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer
81. Misoprostol reduces gastroduodenal injury from one week of aspirin
82. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management
83. Prevention of disuse muscle atrophy in chronic arthritides
84. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid
85. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly
86. Gold therapy in the elderly rheumatoid arthritis patient
87. New therapies for the rheumatic diseases
88. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension
89. Follow-up electron microscopic analysis of sequential liver biopsies from patients with rheumatoid arthritis treated with methotrexate
90. Does aggressive therapy of rheumatoid arthritis affect outcome?
91. Short term effects of low dose prednisone therapy on bone mineral density in patients with rheumatoid arthritis
92. Low dose prednisone, 5 mg, suppresses the hypothalamic-pituitary-adrenal axis
93. Renal effects of nonsteroidal anti-inflammatory drugs: heightened risk to the elderly?
94. Long term evaluation of late onset rheumatoid arthritis: Natural history and therapeutic requirements
95. Ulcer complications and nonsteroidal anti-inflammatory drugs
96. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other antiinflammatory agents
97. Double-blind placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum
98. A double blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms
99. An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen
100. A comparative endoscopic evaluation of the damaging effects of nonsteroidal antiinflammatory agents on the gastric and duodenal mucosa
101. Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs
102. The safe use of anaesthetics and muscle relaxants in older surgical patients
103. Multicenter double-blind trial of interferon-gamma versus placebo in rheumatoid arthritis
104. Alternative therapies for high-risk elderly rheumatic patients
105. Low dose adrenocorticosteroids in the management of elderly patients with rheumatoid arthritis: selected examples and summary of efficacy in the long term management of 97 patients
106. Chloroquine and hydroxychloroquine in rheumatological therapy
107. A study of the long term efficacy and toxicity of cyclosporin A in rheumatoid arthritis
108. Randomised study of the influence of nonsteroidal antiinflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease
109. Is chloroquine obsolete in treatment of rheumatic disease?
110. Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide
111. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies
112. Methotrexate treatment termination in patients with rheumatoid arthritis
113. Some nonsteroidal antiinflammatory drugs inhibit the generation of Superoxide anions by activated polymorphs by blocking ligand-receptor interactions
114. Epidemiology
115. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis
116. Rheumatoid arthritis in the elderly
117. Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin
118. Combination therapy with pulse methylprednisolone in rheumatoid arthritis
119. Nonsteroidal anti-inflammatory agents
120. Total lymphoid irradiation in patients with refractory rheumatoid arthritis
121. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine
122. Disease-modifying agents and immunosuppressive drugs in the elderly
123. Drug therapy in the elderly
124. Aspiration and injection of joints and soft tissues
125. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis
126. Treatment of rheumatoid arthritis with sulfasalazine: Treatment continuation and adverse effects
127. Sulfasalazine in rheumatoid arthritis
128. Corticosteroid user and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs
129. Effects of age and sex on piroxicam disposition
130. Pharmacokinetics of azapropazone in the elderly
131. Multidisciplinary ambulatory care for the elderly arthritis patient
132. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs
133. NSAID and gastropathy: A rheumatologist’s review
134. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long term evaluation
135. Antimalarial drugs
136. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients
137. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease
138. Serial liver biopsies from methotrexate-treated rheumatoid arthritis patients
139. Salicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin
140. Nonsteroidal and analgesic therapy in the elderly
141. Variations in response to nonsteroidal anti-inflammatory drugs
142. Long-term methotrexate therapy for rheumatoid arthritis
143. Effects of sulindac and indomethacin on renal prostaglandin synthesis
144. Effect of nonsteroidal anti-inflammatory drugs on dyspeptic symptoms
145. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis
146. Low dose methotrexate with leucovorin rescue in the management of rheumatoid arthritis
147. Nonsteroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly
148. Nonsteroidal anti-inflammatory drug ingestion: Retrospective study of 272 bleeding or perforated peptic ulcers
149. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. 1. Clinical effects
150. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease
151. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer
152. Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa
153. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis: a double-blind, randomized trial
154. Acute and chronic effects of sulindac on renal function in chronic renal disease
155. Long-term follow-up of rheumatoid arthritis patients treated with total lymphoid irradiation
156. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group
157. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis
158. Rheumatoid arthritis treated with chlorambucil. A five-year follow-up
159. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients
160. Naproxen pharmacokinetics in the elderly
161. Immunosuppressive therapy in rheumatoid arthritis
162. Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective follow-up study of early rheumatoid arthritis
163. Interferon-gamma in RA — a double blind study comparing human recombinant interferon gamma with placebo
164. Rheumatoid vasculitis, survival and associated risk factors
165. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
166. Rising frequency of ulcer perforation in elderly people in the United Kingdom
167. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis
168. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin
169. Methotrexate
170. Efficacy of low-dose methotrexate in rheumatoid arthritis
171. Minimization of indomethacin-induced reduction in renal function by misoprostol
172. Corticosteroids in rheumatoid arthritis
173. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure
174. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis
175. The effect of age on methotrexate efficacy and toxicity
176. Improvement in gold treated rheumatoid arthritis patients: A second look at gold effectiveness in the community
177. Effect of nonsteroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics
178. Assessment of cognitive function in elderly patients treated with naproxen: a prospective study